Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

145.34 -2.25 (-1.52%)
Streaming Delayed Price Updated: 10:20 AM EDT, Apr 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Johnson & Johnson

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
From Johnson & Johnson
Via Business Wire
Four Healthcare Stocks To Watch This Week
Healthcare has long been a wise investment, as the industry consistently grows yearly. Some analysts believe that trend will continue. 
Via MarketBeat
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry. 
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
Healthcare and Medical Leaders Gather to Shape the Future of Global Health
Via ACN Newswire
Topics Economy
Exposures Economy
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
Learn more about Organicell Regenerative Medicine, Inc.from this latest report. 
Via TheNewswire.com
Exposures COVID-19 Product Safety
Spotlight on Healthcare Collaboration and Innovation at Asia Summit on Global Health and HK International Medical and Healthcare Fair
Via ACN Newswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Oyster Point Pharma, Inc. (Nasdaq - OYST), Benefitfocus, Inc. (Nasdaq - BNFT), Abiomed, Inc. (Nasdaq - ABMD), Atlas Corp. (NYSE - ATCO)
From Brodsky & Smith LLC
Via GlobeNewswire
Blue Chip Stocks and Dividend Yields
How to invest in blue chip stocks, exactly? The short answer: carefully, just like with any other investment. Investing in blue-chip stocks depends on your preferences, risk tolerance, portfolio... 
Via MarketBeat
Johnson & Johnson (NYSE: JNJ) Set to Acquire Abiomed (NASDAQ: ABMD) for $16.6 Billion or $380 per Share Plus CVR
Abiomed, Inc. (NASDAQ: ABMD) is engaged as a medical technology company, which is focused on providing support and resources to 
Via Spotlight Growth
Exposures Product Safety
Johnson & Johnson to Acquire Abiomed
From Johnson & Johnson
Via Business Wire
Inaugural International Healthcare Week promotes Hong Kong as leading healthcare hub
Via ACN Newswire
Exposures COVID-19
Eli Lilly Dividend: Does Eli Lilly Pay Dividends?
Yes, Eli Lilly and Company (NYSE: LLY) pays dividends but there is more to investing in this stock than a simple “yes” answer. The Eli Lilly dividend is safe enough but it may not be right for all... 
Via MarketBeat
MarketBeat: Week in Review 10/17-10/21
Stocks are staging a rally to end the week. But economic data next week may bring more volatility. Here are some of the most popular articles from this week 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Merck Nears Breakout Point After October Surprise Good News
Dow component Merck is within 2% of an all-time high after rallying 7.30% in the past month. It got a boost from news about two new treatments. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Does J&J Have Enough Alpha to Be a Solid Low Beta Stock?
JNJ stock is seen as a defensive play which has typically done well in bear markets. But there is one issue that makes longer-term forecasts uncertain 
Via MarketBeat
Topics Economy
Exposures Economy
Johnson & Johnson Reports Q3 2022 Results
From Johnson & Johnson
Via Business Wire
Is Pfizer Stock Still Worth Buying After the Pandemic?
Pharmaceutical giant Pfizer (NYSE: PFE) is literally synonymous with COVID-19 vaccines, and as a result, Pfizer stock continues to beat expectations. 
Via MarketBeat
Exposures COVID-19
Janssen celebrates World Mental Health Day to raise awareness on the importance of timely diagnosis and treatment
Janssen, Pharmaceutical Companies of Johnson & Johnson, is immensely proud of the many ground-breaking mental health innovations has pioneered over the course of its 60+ year legacy in the field. 
Via Newswire.com
Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
From Johnson & Johnson
Via Business Wire
3 Defensive Stocks With 60-Year Dividend Hike Streaks
With the U.S. economy staring at another recession, it may be a good time to lean on the stability and income of the dividend growth champs. 
Via MarketBeat
Topics Economy
Exposures COVID-19 Economy
Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area
From Johnson & Johnson
Via Business Wire
Oracle’s Short-Term Pain Could Be Your Long-Term Gain
Database and cloud solutions provider Oracle (NASDAQ: ORCL) stock got smoked on its fiscal Q1 2023 earnings report. Shares were holding up relatively 
Via MarketBeat
Johnson & Johnson Announces $5 Billion Share Repurchase Program
From Johnson & Johnson
Via Business Wire
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
From Johnson & Johnson
Via Business Wire
Monkeypox vaccine and research related stocks taking center stage (VRAX,GOVX,TNXP,APDN)
Via AB Newswire
Exposures COVID-19
aCommerce and Johnson & Johnson Launch Sustainable Packaging Solution for a Better E-commerce Future in the Philippines
Via ACN Newswire
Worldwide Acne Treatment Market Is Projected to Reach About USD 8.69 Billion by 2028, with a CAGR of 5.1%
Acne Treatment Market SWOT Analysis Including Key Players Allergan plc, Almirall, S.A., Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestle S.A.), GlaxoSmithKline Plc (GSK),... 
Via SBWire
Shock Absorbers: 3 Low Volatility Dividend Stocks for Bumpy Times
Low volatility dividend plays are built to show their worth over time. These three stocks have historically helped navigate investors through turbulent waters. 
Via MarketBeat
Topics Economy Stocks
Exposures Interest Rates US Equities
Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New Consumer Health Company
From Johnson & Johnson
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.